Neurological and neuropsychiatric syndromes associated with liver disease

AIDS

Volumn 19, Issue SUPPL. 3, 2005, Pages

  Weissenborn, Karin ^a   Bokemeyer, Martin ^a   Krause, Jochen ^a   Ennen, Jochen ^a   Ahl, Björn ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Acute liver failure; Chronic fatigue; Hepatic encephalopathy; Hepatic myelopathy; Hepatitis C

Indexed keywords

BRAIN DYSFUNCTION; BRAIN EDEMA; BRAIN METABOLISM; CENTRAL NERVOUS SYSTEM FUNCTION; COGNITIVE DEFECT; CONSCIOUSNESS DISORDER; DAILY LIFE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FATIGUE; FREQUENCY ANALYSIS; HEPATIC ENCEPHALOPATHY; HEPATITIS C VIRUS; HUMAN; HYPOGLYCEMIA; HYPOXIA; INTRACRANIAL PRESSURE; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FAILURE; LIVER FUNCTION; MENTAL DISEASE; MONITORING; MOOD DISORDER; NEUROLOGIC DISEASE; NEUROPHYSIOLOGY; NEUROPSYCHIATRY; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; REVIEW; SEIZURE; SPASTIC PARAPLEGIA; SPINAL CORD DISEASE;

EID: 27944445780     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aids.0000192076.03443.6d     Document Type: Review

References (33)

1. Summerskill WHJ, Davidson EA, Sherlock S, Steiner RE. The neuropsychiatric syndrome associated with hepatic cirrhosis and an extensive portal collateral circulation. Q J Med 1956; XXV:245-266.
2. Sherlock S, Summerskill WHJ, White LP, Phear EA. Portal-systemic encephalopathy. Neurological complications of liver disease. Lancet 1954; I:453-457.
3. Ellis AJ, Wendon JA, Williams R. Subclinical seizure activity and prophylactic phenytoin infusion in acute liver failure: a controlled clinical trial. Hepatology 2000; 32:536-541.
4. Schomerus H, Schreiegg J. Prevalence of latent portasystemic encephalopathy in an unselected population of patients with liver cirrhosis in general practice. Z Gastroenterol 1993; 31:231-234.
5. Bustamante J, Rimola A, Ventura PJ, Navasa M, Cirera I, Reggiardo V, et al. Prognostic significance of hepatic encephalopathy in patients with cirrhosis. J Hepatol 1999; 30:890-895.
6. Pomier Layrargues G. Movement dysfunction and hepatic encephalopathy. Metab Brain Dis 2001; 16:27-36.
7. Read A, Sherlock S, Laidlaw J, Walker JG. The neuro-psychiatric syndromes associated with chronic liver disease and an extensive portal-systemic collateral circulation. Q J Med 1967; XXXVI:135-150.
8. Weissenborn K. Assessment of hepatic encephalopathy. In: Encephalopathy and nitrogen metabolism in liver failure. Edited by Jones EA, Meijer AJ, Chamuleau RAFM. Dordrecht: Kluwer Academic Publishers; 2003. pp. 43-54.
9. Gilberstadt SJ, Gilberstadt H, Zieve L, Buegel B, Collier RO Jr, McClain CJ. Psychomotor performance defects in cirrhotic patients without overt encephalopathy. Arch Intern Med 1980; 140:519-521.
10. Rikkers L, Jenko P, Rudman D, Freides D. Subclinical hepatic encephalopathy: detection, prevalence, and relationship to nitrogen metabolism. Gastroenterology 1978; 75:462-469.
11. Tarter RE, Hegedus AM, Van Thiel DH, Schade RR, Gavaler JS, Starzl TE. Nonalcoholic cirrhosis associated with neuropsychological dysfunction in the absence of overt evidence of hepatic encephalopathy. Gastroenterology 1984; 86:1421-1427.
12. McCrea M, Cordoba J, Vessey G, Blei AT, Randolph C. Neuropsychological characterization and detection of subclinical hepatic encephalopathy. Arch Neurol 1996; 53:758-763.
13. Schomerus H, Hamster W. Neuropsychological aspects of portal-systemic encephalopathy. Metab Brain Dis 1998; 13:361-377.
14. Kullmann F, Hollerbach S, Holstege A, Schölmerich J. Subclinical hepatic encephalopathy: the diagnostic value of evoked potentials. J Hepatol 1995; 22:101-110.
15. Lockwood AH. What's in a name?" Improving the care of cirrhotics. J Hepatol 2000; 32:859-861.
16. Ferenci P, Lockwood AH, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy - definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congress of Gastroenterology, Vienna 1998. Hepatology 2002; 35:716-721.
17. Weissenborn K, Ennen JC, Schomerus H, Rückert N, Hecker H. Neuropsychological characterization of hepatic encephalopathy. J Hepatol 2001; 34:768-773.
18. Hartmann IJC, Groeneweg M, Quero JC, Beijeman SJ, de Man RA, Hop WC, et al. The prognostic significance of subclinical hepatic encephalopathy. Am J Gastroenterol 2000; 95:2029-2034.
19. Krieger S, Jauss M, Jansen O, Theilmann L, Geissler M, Krieger D. Neuropsychiatric profile and hyperintense globus pallidus on T1-weighted magnetic resonance images in liver cirrhosis. Gastroenterology 1996; 111:147-155.
20. Cadranel JF, Lebiez E, Di Martino V, Bernard B, El Koury S, Tourbah A, et al. Focal neurological signs in hepatic encephalopathy in cirrhotic patients: an underestimated entity? Am J Gastroenterol 2001; 96:515-518.
21. Posner MI, Fan J. Attention as an organ system. In: Pomerantz J, editor. Neurobiology of perception and communication: from synapse to society. The IVth De Lange Conference. Cambridge UK: Cambridge University Press; 2005. In press.
22. Lockwood AH, Weissenborn K, Bokemeyer M, Tietge U, Burchert W. Correlations between cerebral glucose metabolism and neuropsychological test performance in nonalcoholic cirrhotics. Metab Brain Dis 2002; 17:29-40.
23. Weissenborn K, Heidenreich S, Giewekemeyer K, Rückert N, Hecker H. Memory function in early hepatic encephalopathy. J Hepatol 2003; 39:320-325.
24. Weissenborn K, Kolbe H. The basal ganglia and portal-systemic encephalopathy. Metab Brain Dis 1998; 13:261-272.
25. Jöbges EM, Heidemann M, Hecker H, Ennen JC, Weissenborn K. Bradykinesia in minimal hepatic encephalopathy (HE) is due to disturbances in movement initiation. J Hepatol 2003; 38:273-280.
26. Weissenborn K, Tietge UJF, Bokemeyer M, Bode U, Manns MP, Caselitz M. Liver transplantation improves hepatic myelopathy - evidence by three cases. Gastroenterology 2003; 124:346-351.
27. Barkhuizen A, Rosen HR, Wolf S, Flora K, Benner K, Bennett RM. Muskuloskeletal pain and fatigue are associated with chronic hepatitis C. A report of 239 hepatology clinic patients. Am J Gastroenterol 1999; 94:1355-1360.
28. Poynard T, Cacoub P, Ratziu V, Myers RP, Dezailles MH, Mercadier A, et al., for the Multivirc Group. Fatigue in patients with chronic hepatitis C. J Viral Hepat 2002; 9:295-303.
29. Foster GR, Goldin RD, Thomas HC. Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis. Hepatology 1998; 27:209-212.
30. Cacoub P, Ratziu V, Myers RP, Ghillani P, Piette JC, Moussalli J, et al., for the Multivirc Group. Impact of treatment on extra hepatic manifestations in patients with chronic hepatitis C. J Hepatol 2002; 36:812-818.
31. Forton DM, Thomas HC, Murphy CA, Allsop JM, Foster GR, Main J, et al. Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease. Hepatology 2002; 35:433-439.
32. Weissenborn K, Krause J, Schüler A, Ennen JC, Ahl B, Hecker H, et al. Hepatitis C virus infection affects the brain - evidence by psychometric studies and magnetic resonance spectroscopy. J Hepatol 2004; 41:845-851.
33. Hilsabeck RC, Perry W, Hassanein TI. Neuropsychological impairment in patients with chronic hepatitis C. Hepatology 2002; 35:440-446.